Efficacy and safety of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials. J of Skin [Internet]. 2022 Nov. 16 [cited 2026 Apr. 17];6(6):s76. Available from: https://skin.dermsquared.com/skin/article/view/1834